National Institute of Mental Health (NIMH)

Search Our Work by NIH Institute/Center

Partnerships with this Institute

Key Initiatives, Research Partners

This groundbreaking initiative expands the science of targeted medicine. The study of biomarkers creates the potential to individualize medical treatment by determining how a drug works in the body and identifying patients likely to respond to targeted medicines and therapies.

Program, Research Partners

Schizophrenia is a chronic, severe brain disorder that affects over one percent of the U.S. population. Because many sufferers have difficulty holding a job or caring for themselves, the burden on their families and society is significant. Current treatments fall short of relieving many symptoms.

Completed Programs, Past Programs

The goal of this multi-year project is to evaluate schizophrenia medications as they relate to indicators for cardiovascular disease and disease stability, and to determine treatment effectiveness.